{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:26:54Z","timestamp":1793593614087,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.nucmedbio.2026.109847","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:51:53Z","timestamp":1792360313000},"page":"109847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical evaluation of a CD137-targeted PET tracer for detection of inflammatory arthritis"],"prefix":"10.1016","volume":"162-163","author":[{"given":"Luna","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongpeng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nucmedbio.2026.109847_bb0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0010","first-page":"26","article-title":"Glucagon-like peptide 1 receptor agonists in patients with inflammatory arthritis or psoriasis: a scoping review","volume":"30","author":"Karacabeyli","year":"2024","journal-title":"J Clin Rheumatol Pract Reports Rheumatic Musculoskeletal Dis"},{"issue":"9","key":"10.1016\/j.nucmedbio.2026.109847_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158783","article-title":"The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis","volume":"7","author":"de la Calle-Fabregat","year":"2022","journal-title":"JCI Insight"},{"issue":"13","key":"10.1016\/j.nucmedbio.2026.109847_bb0020","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1021\/acs.analchem.5c00023","article-title":"Intelligent bi-dimensional skin biopsies of rheumatoid arthritis based on Raman spectral imaging and machine learning","volume":"97","author":"Ma","year":"2025","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat Immunol"},{"issue":"7987","key":"10.1016\/j.nucmedbio.2026.109847_bb0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.nucmedbio.2026.109847_bb0035","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/art.42960","article-title":"CD4(+)CD8\u03b1(low) T cell clonal expansion dependent on costimulation in patients with rheumatoid arthritis","volume":"76","author":"Beck","year":"2024","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cei\/uxae031","article-title":"Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?","volume":"217","author":"Shah","year":"2024","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.nucmedbio.2026.109847_bb0045","article-title":"CD137 as an attractive T cell co-stimulatory target in the TNFRSF for immuno-oncology drug development","volume":"13","author":"Hashimoto","year":"2021","journal-title":"Cancers Basel"},{"issue":"10","key":"10.1016\/j.nucmedbio.2026.109847_bb0050","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/2326-6066.CIR-19-0115","article-title":"Metabolic consequences of T-cell costimulation in anticancer immunity","volume":"7","author":"Teijeira","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0055","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1038\/s41467-021-27613-w","article-title":"CD137 (4-1BB) costimulation of CD8(+) T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation","volume":"12","author":"Otano","year":"2021","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.nucmedbio.2026.109847_bb0060","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1107","article-title":"4-1BB-mediated immunotherapy of rheumatoid arthritis","volume":"10","author":"Seo","year":"2004","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.nucmedbio.2026.109847_bb0065","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1038\/s41375-021-01287-1","article-title":"CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes\/macrophages enhancing their tumoricidal activity","volume":"35","author":"Stoll","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00259-022-05946-y","article-title":"Fluorophore-conjugated 4-1BB antibody enables early detection of T-cell responses in inflammatory arthritis via NIRF imaging","volume":"50","author":"Duan","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109847_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120630","article-title":"A dual-modal PET\/near infrared fluorescent nanotag for long-term immune cell tracking","volume":"269","author":"Harmsen","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.nucmedbio.2026.109847_bb0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2214\/AJR.16.16181","article-title":"Dual PET and Near-infrared fluorescence imaging probes as tools for imaging in oncology","volume":"207","author":"An","year":"2016","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0085","first-page":"40","article-title":"Preclinical evaluation and pilot clinical study of CD137 PET radiotracer for noninvasive monitoring early responses of immunotherapy","volume":"66","author":"Cheng","year":"2025","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"2","key":"10.1016\/j.nucmedbio.2026.109847_bb0090","doi-asserted-by":"crossref","first-page":"ITC17","DOI":"10.7326\/AITC202402200","article-title":"Immune-related adverse events of immune checkpoint inhibitors","volume":"177","author":"Ramos-Casals","year":"2024","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11926-024-01173-6","article-title":"Immune checkpoint inhibitor associated rheumatoid arthritis","volume":"27","author":"Bernabela","year":"2024","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.nucmedbio.2026.109847_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002511","article-title":"Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis","volume":"8","author":"Cappelli","year":"2022","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103943","article-title":"Immune checkpoint inhibitor-induced inflammatory arthritis vs rheumatoid arthritis: a comparative review","volume":"25","author":"Georgios","year":"2026","journal-title":"Autoimmun Rev"},{"issue":"16","key":"10.1016\/j.nucmedbio.2026.109847_bb0110","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1158\/1078-0432.CCR-20-4894","article-title":"Select antitumor cytotoxic CD8(+) T clonotypes expand in patients with chronic lymphocytic leukemia treated with ibrutinib","volume":"27","author":"Baptista","year":"2021","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109847_bb0115","article-title":"Resolving complexity: Identification of altersetin and toxin mixtures responsible for the immunomodulatory, antiestrogenic and genotoxic potential of a complex Alternaria mycotoxin extract","volume":"198","author":"Partsch","year":"2025","journal-title":"Food Chem Toxicol Int J Brit Ind Biol Res Assoc"},{"issue":"5","key":"10.1016\/j.nucmedbio.2026.109847_bb0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41401-020-00507-1","article-title":"Deficiency of \u03b2-arrestin2 exacerbates inflammatory arthritis by facilitating plasma cell formation","volume":"42","author":"Zhou","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.nucmedbio.2026.109847_bb0125","article-title":"TNF-\u03b1 inhibitor ameliorates immune-related arthritis and pneumonitis in humanized mice","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.nucmedbio.2026.109847_bb0130","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1007\/s00259-022-05836-3","article-title":"Preclinical evaluation and pilot clinical study of [(18)F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis","volume":"49","author":"Ge","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.nucmedbio.2026.109847_bb0135","first-page":"431","article-title":"4-1BB targeting immunotherapy: mechanism, antibodies, and chimeric antigen receptor T","volume":"38","author":"Shen","year":"2023","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0140","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2167189","article-title":"The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy","volume":"15","author":"Claus","year":"2023","journal-title":"MAbs"},{"issue":"10416","key":"10.1016\/j.nucmedbio.2026.109847_bb0145","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109847_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/annrheumdis-2020-217139","article-title":"EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors","volume":"80","author":"Kostine","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.nucmedbio.2026.109847_bb0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bulcan.2021.01.016","article-title":"Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)","volume":"108","author":"Tingry","year":"2021","journal-title":"Bull Cancer"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126002465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126002465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T03:54:06Z","timestamp":1793591646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126002465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S0969805126002465"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109847","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of a CD137-targeted PET tracer for detection of inflammatory arthritis","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109847"}}